Edap Tms SA (NASDAQ:EDAP) has earned an average broker rating score of 1.00 (Strong Buy) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.
Brokerages have set a 1 year consensus target price of $6.50 for the company and are anticipating that the company will post $0.01 EPS for the current quarter, according to Zacks. Zacks has also given Edap Tms an industry rank of 84 out of 256 based on the ratings given to its competitors.
Several equities analysts have issued reports on the stock. HC Wainwright set a $7.00 price objective on shares of Edap Tms and gave the company a “buy” rating in a research note on Tuesday, June 11th. TheStreet cut shares of Edap Tms from a “b-” rating to a “d+” rating in a research note on Monday, June 17th. ValuEngine cut shares of Edap Tms from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Zacks Investment Research raised shares of Edap Tms from a “sell” rating to a “hold” rating in a research note on Tuesday, July 16th.
Hedge funds and other institutional investors have recently modified their holdings of the business. Hilton Capital Management LLC purchased a new stake in shares of Edap Tms in the 1st quarter worth about $75,000. Fosun International Ltd boosted its position in shares of Edap Tms by 45.9% in the 1st quarter. Fosun International Ltd now owns 363,485 shares of the medical equipment provider’s stock worth $1,072,000 after buying an additional 114,342 shares in the last quarter. Susquehanna International Group LLP boosted its position in shares of Edap Tms by 762.9% in the 2nd quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 181,401 shares in the last quarter. Morgan Stanley boosted its position in shares of Edap Tms by 222.7% in the 2nd quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after buying an additional 184,539 shares in the last quarter. Finally, Acadian Asset Management LLC purchased a new stake in shares of Edap Tms in the 2nd quarter worth about $607,000. Institutional investors own 11.77% of the company’s stock.
Shares of Edap Tms stock remained flat at $$3.20 during trading on Thursday. 2,080 shares of the stock were exchanged, compared to its average volume of 291,699. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.97 and a current ratio of 2.40. The company has a market capitalization of $87.28 million, a price-to-earnings ratio of 159.95 and a beta of 1.76. The stock has a fifty day moving average price of $2.91 and a 200-day moving average price of $3.30. Edap Tms has a fifty-two week low of $1.35 and a fifty-two week high of $5.42.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Featured Article: Buy-Side Analysts
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.